| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1346597-58-7 | N-(2-(1,3-Dioxolan-2-yl)phenyl)carbamic acid phenylmethyl ester | C17H17NO4 |
| 1346597-81-6 | Bupivacaine N-Oxide HCl | C18H28N2O2 |
| 1346597-97-4 | rac-trans-4-Defluoro-4-ethoxy Paroxetine Hydrochloride;(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-ethoxyphenyl)piperidine;hydrochloride | C21H26ClNO4 |
| 1346598-11-5 | Domperidone EP Impurity B;4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine | C13H14ClN3O2 |
| 1346598-86-4 | Sodium (3R,5R)-7-(2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate | C33H34FN2NaO5 |
| 1346599-09-4 | 1-(3-(Methylamino)-1-(2-thienyl)propyl)-2-naphthalenol | C18H19NOS |
| 1346600-38-1 | rac Dehydro-O-desmethyl Venlafaxine;4-(1-(cyclohexen-1-yl)-2-(dimethylamino)ethyl)phenol | C16H23NO |
| 1346600-40-5 | 3-Fluoroephedrone Hydrochloride | C10H13ClFNO |
| 1346600-85-8 | Zolpidem EP Impurity A;6-(Desmethyl)-7-methyl zolpidem | C19H21N3O |
| 1346601-03-3 | 3-Indoxyl Sulfate-d4 Potassium Salt | C8H2D4KNO4S |
| 1346601-52-2 | 4-Methyl Erlotinib;4-Methyl Erlotinib Hydrochloride | C23H25N3O4 |
| 1346601-75-9 | Bisoprolol EP Impurity N;1-(4-(2-ethoxyethoxymethyl)phenoxy)-3-(propan-2-ylamino)propan-2-ol | C17H29NO4 |
| 1346601-76-0 | N-Formyl Oxcarbazepine | C16H12N2O3 |
| 1346602-28-5 | Risperidone EP Impurity E;6-Methylrisperidone;3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-2,6-dimethyl-6,7,8,9-tetrahydropyrido(1,2-a)pyrimidin-4-one | C24H29FN4O2 |
| 1346603-25-5 | rel-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aR,7aR)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1) | C21H24FN3O4.HCl |
| 1346603-41-5 | N-Nitrosodiethylamine-d4;N-ethyl-N-(1,1,2,2-tetradeuterioethyl)nitrous amide | C4D4H6N2O |
| 1346604-13-4 | Allopurinol EP Impurity C;5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide | C6H6N6O |
| 1346604-18-9 | Oseltamivir EP Impurity D;Ethyl 4-acetamido-3-hydroxybenzoate | C11H13NO4 |
| 1346604-70-3 | Candesartan-d4 | C24H16D4N6O3 |
| 1346669-48-4 | 9-(1,1'-biphenyl)-4-yl-3,3'-bi-9H-carbazole;3-(9H-carbazol-3-yl)-9-(4-phenylphenyl)carbazole | C36H24N2 |
| 1346674-23-4 | 3,4,7,8-Tetrahydro-7,7-dimethyl-2H-cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-1(6H)-one;4,4-Dimethyl-1,10-diazatricyclo(6.4.0.0(2,6))dodeca-2(6),7-dien-9-one | C12H16N2O |
| 1346688-54-7 | 2,6-Dibromo-4-octyl-4H-dithieno(3,2-b:2',3'-d)pyrrole | C16H19Br2NS2 |
| 1346702-53-1 | Methyl 6-bromo-2-(1-methylethyl)-2H-indazole-4-carboxylate | C12H13BrN2O2 |
| 1346704-33-3 | 1-(1-Methylethyl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl)-6-(2-(4-methyl-1-piperazinyl)-4-pyridinyl)-1H-indazole-4-carboxamide | C31H39N7O2 |
| 1346747-38-3 | Fingolimod-d4;2-Amino-1,1,3,3-tetradeuterio-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol | C19H29D4NO2 |
| 1346747-65-6 | N-Methyl valacyclovir;2-((2-amino-6-oxo-1H-purin-9-yl)methoxy)ethyl (2S)-3-methyl-2-(methylamino)butanoate | C14H22N6O4 |
| 1346747-69-0 | N-Ethyl valacyclovir;Valaciclovir impurity D;2-((2-amino-6-oxo-1H-purin-9-yl)methoxy)ethyl (2S)-2-(ethylamino)-3-methylbutanoate | C15H24N6O4 |
| 1346792-67-3 | 9-(3-(9H-Carbazol-9-yl)phenyl)-3-(4-(1-phenyl-1H-benzimidazol-2-yl)phenyl)-9H-carbazole | C49H32N4 |
| 1346808-41-0 | 5-Methylisoxazole-4-boronic acid pinacol ester;5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | C10H16BNO3 |
| 1346809-61-7 | 3-bromo-5H-pyrrolo(3,4-b)pyridin-7(6H)-one | C7H5BrN2O |
| 1347736-74-6 | 4,7-Dibromo-5-fluoro-2,1,3-benzothiadiazole;4,7-Dibromo-5-fluorobenzo(c)(1,2,5)thiadiazole | C6HBr2FN2S |
| 1347750-75-7 | 5,8,11-Trioxa-2-azatetradecanedioic acid 1-(1,1-dimethylethyl) ester | C14H27NO7 |
| 1348664-75-4 | alpha-(2-Fluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol | C13H13FN6O |
| 1349151-98-9 | 1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic acid pinacol ester;1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | C14H22BNO3 |
| 1349171-28-3 | 2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | C17H20BNO2 |
| 1349199-61-6 | Tert-butyl 3-oxo-1-oxa-6-azaspiro[3.3]heptane-6-carboxylate | |
| 1349199-63-8 | Tert-butyl 3-hydroxy-1-oxa-6-azaspiro[3.3]heptane-6-carboxylate | |
| 1349708-91-3 | 4-Bromo-5-chloro-2-fluorobenzoic acid | C7H3BrClFO2 |
| 1349715-77-0 | ((2-Fluorophenyl)methyl)hydrazine hydrochloride (1:2) | C7H9FN2.2(HCl) |
| 1349718-54-2 | 3,4-Dichloro-2-fluorobenzaldehyde | C7H3Cl2FO |
| 1349718-98-4 | 2,4-Dichloro-6-fluorobenzonitrile | C7H2Cl2FN |
| 1349723-93-8 | Elacestrant dihydrochloride;(6R)-6-(2-(Ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-2-naphthalenol hydrochloride (1:2); Elacestrant hydrochloride; RAD 901 dihydrochloride | C30H38N2O2 .2ClH |
| 1349796-36-6 | N-(4-(((3-((3,5-Dimethoxyphenyl)amino)-2-quinoxalinyl)amino)sulfonyl)phenyl)-3-methoxy-4-methylbenzamide | C31H29N5O6S |
| 1350323-88-4 | 5-Methoxy-1-methyl-1H-pyrazole | C5H8N2O |
| 1350377-66-0 | 3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | C13H20BNO3 |
| 1350514-68-9 | Grazoprevir;(1R,2S)-N-((((1R,2R)-2-(5-(3-Hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide cyclic (1→2)-ether; ; MK 5172 | C38H50N6O9S |
| 1350543-95-1 | 3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridazine | C11H17BN2O2 |
| 1350547-65-7 | UNC569;1-((4-aminocyclohexyl)methyl)-N-butyl-3-(4-fluorophenyl)pyrazolo(3,4-d)pyrimidin-6-amine | C22H29FN6 |
| 1350549-36-8 | UNC 1025;4-(6-(butylamino)-3-(4-morpholin-4-ylsulfonylphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)cyclohexan-1-ol | C25H34N6O4S |
| 1350622-33-1 | 9-(((1,1-Dimethylethyl)dimethylsilyl)oxy)-1,2,3,4-tetrahydro-5H-(1)benzopyrano(3,4-b)pyridin-5-one | C18H25NO3Si |